Vivos Therapeutics (VVOS) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Vivos Therapeutics (VVOS) over the last 7 years, with Q3 2025 value amounting to $4.8 million.
- Vivos Therapeutics' Other Gross PP&E Adjustments fell 202.0% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 202.0%. This contributed to the annual value of $4.4 million for FY2024, which is 1882.89% up from last year.
- Latest data reveals that Vivos Therapeutics reported Other Gross PP&E Adjustments of $4.8 million as of Q3 2025, which was down 202.0% from $4.4 million recorded in Q2 2025.
- Vivos Therapeutics' 5-year Other Gross PP&E Adjustments high stood at $4.9 million for Q3 2024, and its period low was $1.9 million during Q1 2021.
- In the last 5 years, Vivos Therapeutics' Other Gross PP&E Adjustments had a median value of $3.7 million in 2023 and averaged $3.6 million.
- As far as peak fluctuations go, Vivos Therapeutics' Other Gross PP&E Adjustments skyrocketed by 13937.97% in 2021, and later plummeted by 3218.11% in 2022.
- Quarter analysis of 5 years shows Vivos Therapeutics' Other Gross PP&E Adjustments stood at $2.5 million in 2021, then dropped by 7.18% to $2.4 million in 2022, then soared by 57.49% to $3.7 million in 2023, then rose by 18.83% to $4.4 million in 2024, then increased by 8.54% to $4.8 million in 2025.
- Its Other Gross PP&E Adjustments stands at $4.8 million for Q3 2025, versus $4.4 million for Q2 2025 and $4.7 million for Q1 2025.